• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Effect of mobile phone text messaging for improving the uptake of influenza vaccination in patients with rare diseases

tetano

Editor, Senior Moderator
Vaccine. 2019 Jul 25. pii: S0264-410X(19)30970-3. doi: 10.1016/j.vaccine.2019.07.062. [Epub ahead of print]
[h=1]Effect of mobile phone text messaging for improving the uptake of influenza vaccination in patients with rare diseases.[/h] Esteban-Vasallo MD[SUP]1[/SUP], Dom?nguez-Berj?n MF[SUP]2[/SUP], Garc?a-Riolobos C[SUP]2[/SUP], Zoni AC[SUP]2[/SUP], Ar?jula Torres JL[SUP]3[/SUP], S?nchez-Perruca L[SUP]3[/SUP], Astray-Mochales J[SUP]4[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] [h=4]OBJECTIVES:[/h] Influenza vaccine is recommended in some chronic medical conditions, including several rare diseases. The objectives of the study were to assess the effect of text message reminders on influenza vaccination uptake of patients with selected rare diseases and delayed vaccination, and to describe their characteristics.
[h=4]METHODS:[/h] Quasi-experimental pre-post intervention study performed along the 2016 influenza vaccination campaign in the Autonomous Community of Madrid. Unvaccinated patients diagnosed with a selected rare disease were targeted for intervention. SMS were sent to them at least one month after the beginning of the campaign, in four consecutive weeks. Those with no mobile phones available or no certainty of message reception, were assigned as controls. The association between the reception of the SMS and vaccination uptake was assessed using multiple poisson regression models.
[h=4]RESULTS:[/h] Of 69.040 patients with delayed vaccination, 87.2% received an SMS reminder in the asigned contact mobile telephone. Global influenza vaccine coverage reached 41.3%. The uptake of influenza vaccine was significantly higher among those receiving the reminder (9.3% vs. 7.1% in the control group, p < 0.001). Those who received a SMS reminder were 30% more likely to uptake seasonal influenza vaccine. By sex and age, the reception of the reminder was associated with a significantly higher probability of vaccination in men ≥65 years with at least a concurrent chronic condition (IRR: 1.58, CI95%: 1.25-2.00). Among women, this higher probability was detected in those between 14 and 64 years of age (IRR: 1.41, CI95%: 1.22-1.63), and ≥65 years without concurrent chronic conditions (IRR: 1.40, CI95%: 1.05-1.89).
[h=4]CONCLUSION:[/h] Although the intervention was modestly effective, it proved beneficial in some cases. It can be an additional strategy to improve vaccine uptake, since it is simple, feasible, affordable and easily scalable, particularly when immunization and target population data are available in population registries.
Copyright ? 2019. Published by Elsevier Ltd.


[h=4]KEYWORDS:[/h] Influenza vaccines; Program evaluation; Rare diseases; Text messaging; Vaccination coverage

PMID: 31353257 DOI: 10.1016/j.vaccine.2019.07.062
 
Back
Top Bottom